Continuous haemodynamic monitoring during exercise in patients with pulmonary hypertension

International Journal of Cardiology

Volumn 101, Issue 3, 2005, Pages 415-420

  Wonisch, Manfred ^a   Fruhwald, Friedrich M ^a   Maier, Robert ^a   Watzinger, Norbert ^a   Hödl, Ronald ^a   Kraxner, Wilfried ^a   Perthold, Wolfgang ^b   Klein, Werner W ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Medtronic Austria   (Austria)

Author keywords

Cardiopulmonary exercise testing; Haemodynamic monitoring; Iloprost; Implantable devices; Pulmonary hypertension

Indexed keywords

ILOPROST;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG RESPONSE; EXERCISE; EXERCISE TEST; FEMALE; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART PRELOAD; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; INOTROPISM; LONG TERM CARE; MONITOR; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REST; SYSTOLIC BLOOD PRESSURE; WORKLOAD;

ADULT; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; MONITORING, AMBULATORY; PULMONARY WEDGE PRESSURE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 19344368674     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.03.054     Document Type: Article

References (30)

1. J.S.R. Gibbs, and T.W. Higenbottam Recommendations on the management of pulmonary hypertension in clinical practice Heart 86 Suppl. I 2001 i1 i13
2. N. Nagaya, Y. Shimizu, T. Satoh, H. Oya, M. Uematsu, and S. Kyotani Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboemolic pulmonary hypertension Heart 87 2002 340 345
3. R. Wensel, C.F. Opitz, R. Ewert, L. Bruch, and F.X. Kleber Effects of iloprost on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension Circulation 101 2000 2388 2392
4. X.-G. Sun, J.E. Hansen, R.J. Oudiz, and K. Wasserman Exercise pathophysiology in patients with primary pulmonary hypertension Circulation 104 2001 429 435
5. J.L. Fleg, I.L. Pina, J.G. Balady, B.R. Chaitman, B. Fletcher, and C. Lavie Assessment of functional capacity in clinical and research applications-an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American Heart Association Circulation 102 2000 1591 1597
6. R. Wensel, C.F. Opitz, R. Ewert, L. Bruch, and F.X. Kleber Assessment of survival in patients with primary pulmonary hypertension-importance of cardiopulmonary exercise testing Circulation 106 2002 319 324
7. F.C. Blumberg, G.A.J. Riegger, and M. Pfeifer Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise Chest 121 2002 1566 1571
8. H. Olschewski, D. Walmrath, R. Schermuly, A. Ghofrani, F. Grimminger, and W. Seeger Aerosolized prostacyclin and iloprost in severe pulmonary hypertension Ann. Intern. Med. 124 1996 820 824
9. H. Olschewski, G. Simonneau, N. Galié, T. Higenbottam, R. Naeije, and L.J. Rubin Inhaled iloprost for severe pulmonary hypertension N. Engl. J. Med. 347 2002 322 329
10. G. Mikhail, J. Gibbs, M. Richardson, G. Wright, A. Khaghani, and N. Banner An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension Eur. Heart J. 18 1997 1499 1504
11. M. Hoeper, H. Olschewski, H. Ghofrani, H. Wilkens, J. Winkler, and M.M. Borst A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension J. Am. Coll. Cardiol. 35 2000 176 182
12. H. Stricker, G. Domenighetti, G. Fiori, and G. Mombelli Sustained improvement of performance and haemodynamics with long-term aerosolized prostacyclin therapy in severe pulmonary hypertension Schweiz. Med. Wochenschr. 129 1999 923 927
13. American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation Pulmonary rehabilitation guidelines panel. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines Chest 112 1997 1363 1396
14. G.F. Fletcher, G. Balady, S.N. Blair, J. Blumenthal, C. Caspersen, and B. Chaitman Statement on exercise: benefits and recommendations for physical activity programs for all Americans Circulation 94 1996 857 862
15. R.J. Shephard, and G.J. Balady Exercise as cardiovascular therapy Circulation 99 1999 963 972
16. T.K. Rogers, and P. Howard Pulmonary hemodynamics and physical training in patients with chronic obstructive pulmonary disease Chest 101 1992 289S 292S
17. F.S.F. Ram, S.M. Robinson, and P.N. Black Effects of physical training in asthma: a systematic review Br. J. Sports Med. 34 2000 162 167
18. A. Ohlsson, R. Nordlander, T. Bennet, C. Bitkover, B. Kjellström, and B. Lee Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique Eur. Heart J. 19 1998 174 184
19. A. Ohlsson, S.H. Kubo, D. Steinhaus, D.T. Conelly, S. Adler, and C. Bitkover Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study Eur. Heart J. 22 2001 942 954
20. F. Braunschweig, C. Linde, M.J. Eriksson, C. Hofman-Bang, and L. Rydén Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure Eur. Heart J. 23 2002 59 69
21. F.M. Fruhwald, B. Kjellström, W. Perthold, N. Watzinger, R. Maier, and P.A. Grandjean Continuous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprost Chest 124 2003 351 359
22. D.W. Reynolds, N. Bartelt, R. Taepke, and T.D. Bennett Measurement of pulmonary artery diastolic pressure from the right ventricle J. Am. Coll. Cardiol. 25 1995 1176 1182
23. W.K. Laskey, V.A. Ferrari, H.I. Palevsky, and W.G. Kussmaul Pulmonary artery hemodynamics in primary pulmonary hypertension J. Am. Coll. Cardiol. 21 1993 406 612
24. A.C. Kao, P. Van Trigt, G. Shaeffer-McCall, J.P. Shaw, B.B. Kuzil, and R.D. Page Central and peripheral limitations to upright exercise in untrained cardiac transplant recipients Circulation 89 1994 2605 2615
25. D.A. Raeside, A. Smith, A. Brown, K.R. Patel, R. Madhok, and J. Cleland Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension Eur. Respir. J. 16 2000 282 287
26. D.A. Oelberg, F. Marcotte, H. Kreisman, N. Wolkove, D. Langleben, and D. Small Evaluation of right ventricular systolic pressure during incremental exercise by doppler echocardiography in adults with atrial septal defect Chest 113 1998 1459 1465
27. V. Petkov, R. Ziesche, W. Mosgoeller, P. Schenk, K. Vonbank, and L. Stiebellehner Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment Thorax 56 2001 734 736
28. P. Schenk, V. Petkov, C. Madl, L. Kramer, M. Kneussl, and R. Ziesche Aerosolized iloprost therapy could not replace long-term iv epoprostenol (prostacyclin) administration in severe pulmonary hypertension Chest 119 2001 296 300
29. S. Machherndl, M. Kneussl, H. Baumgartner, B. Schneider, V. Petkov, and I. Schenk Long-term treatment of pulmonary hypertension with aerosolized iloprost Eur. Respir. J. 17 2001 8 13
30. M.S. Riley, J. Pórszáz, J. Miranda, M.P.K.J. Engelen, B. Brundage, and K. Wasserman Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis Chest 111 1997 44 50